{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:03:47Z","timestamp":1793372627554,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T00:00:00Z","timestamp":1539475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006280","name":"Ministerio de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["107-2634-F-007-006"],"award-info":[{"award-number":["107-2634-F-007-006"]}],"id":[{"id":"10.13039\/501100006280","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006280","name":"Ministerio de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["103-2314-B-002-185-MY2"],"award-info":[{"award-number":["103-2314-B-002-185-MY2"]}],"id":[{"id":"10.13039\/501100006280","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ebiom.2018.10.042","type":"journal-article","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T10:56:18Z","timestamp":1540205778000},"page":"91-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"special_numbering":"C","title":["Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7965-7579","authenticated-orcid":false,"given":"Bor-Sheng","family":"Ko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Fen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeng-Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Fang","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szu-Chun","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-An","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huai-Hsuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Ting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Hau","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hong","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Chung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Ju","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chien","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwei-Fang","family":"Tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0186-4321","authenticated-orcid":false,"given":"Chi-Chun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jih-Luh","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ebiom.2018.10.042_bb0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/jcm5030033","article-title":"Acute myeloid leukemia: A concise review","volume":"5","author":"Saultz","year":"2016","journal-title":"J Clin Med"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0010","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00277-018-3330-9","article-title":"Role of minimal residual disease in the management of acute myeloid leukemia\u2014a case-based discussion","volume":"97","author":"Coltoff","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0015","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1182\/blood-2017-09-801498","article-title":"Minimal\/measurable residual disease in AML: A consensus document from the European LeukemiaNet MRD Working Party","volume":"131","author":"Schuurhuis","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0020","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1182\/blood-2012-02-408336","article-title":"Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group","volume":"120","author":"Loken","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0025","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1182\/blood-2014-05-577593","article-title":"Defining minimal residual disease in acute myeloid leukemia: Which platforms are ready for \"prime time\"?","volume":"124","author":"Grimwade","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00063-005-1122-1","article-title":"Quantification of minimal residual disease by multiparameter flow cytometry in acute myeloid leukemia. From diagnosis to prognosis","volume":"100","author":"Kern","year":"2005","journal-title":"Med Klin (Munich)"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0035","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1200\/JCO.2012.45.9628","article-title":"High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON\/SAKK AML 42A study","volume":"31","author":"Terwijn","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0040","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1200\/JCO.2013.49.1753","article-title":"Prognostic relevance of treatment response measured by flow cytometric residual disease detection in older patients with acute myeloid leukemia","volume":"31","author":"Freeman","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0045","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/sj.leu.2403138","article-title":"Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation","volume":"17","author":"Venditti","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0050","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1182\/blood-2009-12-258178","article-title":"Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia","volume":"116","author":"Buccisano","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ebiom.2018.10.042_bb0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/jcm6060057","article-title":"Minimal residual disease in acute myeloid leukemia: Still a work in progress?","volume":"6","author":"Mosna","year":"2017","journal-title":"J Clin Med"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0060","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nmeth.2365","article-title":"Critical assessment of automated flow cytometry data analysis techniques","volume":"10","author":"Aghaeepour","year":"2013","journal-title":"Nat Methods"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0065","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1182\/asheducation-2014.1.222","article-title":"Defining minimal residual disease in acute myeloid leukemia: Which platforms are ready for \"prime time\"?","volume":"2014","author":"Grimwade","year":"2014","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cytob.21140","article-title":"Residual disease in AML, a target that can move in more than one direction","volume":"86","author":"Loken","year":"2014","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cytob.21134","article-title":"Tumor heterogeneity makes AML a \"moving target\" for detection of residual disease","volume":"86","author":"Zeijlemaker","year":"2014","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0080","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/cyto.a.20901","article-title":"Data analysis in flow cytometry: The future just started","volume":"77","author":"Lugli","year":"2010","journal-title":"Cytometry A"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0085","series-title":"Data Mining: Practical machine learning tools and techniques: Morgan Kaufmann","author":"Witten","year":"2016"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0090","series-title":"Pattern recognition and machine learning: Springer-Verlag New York","author":"Bishop","year":"2006"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0095","series-title":"The discipline of machine learning. School of Computer Science, Carnegie Mellon University","author":"Mitchell","year":"2006"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0100","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.metabol.2017.01.011","article-title":"Artificial intelligence in medicine","volume":"69S","author":"Hamet","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature21056","article-title":"Dermatologist-level classification of skin cancer with deep neural networks","volume":"542","author":"Esteva","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0110","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nature22985","article-title":"Corrigendum: Dermatologist-level classification of skin cancer with deep neural networks","volume":"546","author":"Esteva","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0115","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1200\/JCO.2014.59.1339","article-title":"Prediction of allogeneic hematopoietic stem-cell transplantation mortality 100 days after transplantation using a machine learning algorithm: A European group for blood and marrow transplantation acute leukemia working party retrospective data mining study","volume":"33","author":"Shouval","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0120","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2016.17216","article-title":"Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs","volume":"316","author":"Gulshan","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0125","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1001\/jama.2016.17563","article-title":"Artificial intelligence with deep learning technology looks into diabetic retinopathy screening","volume":"316","author":"Wong","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/eji.201545774","article-title":"The end of gating? An introduction to automated analysis of high dimensional cytometry data","volume":"46","author":"Mair","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0135","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/cyto.a.22446","article-title":"SWIFT-scalable clustering for automated identification of rare cell populations in large, high-dimensional flow cytometry datasets, part 1: Algorithm design","volume":"85","author":"Naim","year":"2014","journal-title":"Cytometry A"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0140","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/cyto.a.22445","article-title":"SWIFT-scalable clustering for automated identification of rare cell populations in large, high-dimensional flow cytometry datasets, part 2: biological evaluation","volume":"85","author":"Mosmann","year":"2014","journal-title":"Cytometry A"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0145","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/cyto.a.22626","article-title":"ImmunoClust--An automated analysis pipeline for the identification of immunophenotypic signatures in high-dimensional cytometric datasets","volume":"87","author":"Sorensen","year":"2015","journal-title":"Cytometry A"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0150","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/1471-2105-7-282","article-title":"Automated in-silico detection of cell populations in flow cytometry readouts and its application to leukemia disease monitoring","volume":"7","author":"Toedling","year":"2006","journal-title":"BMC Bioinform"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0155","series-title":"Lecture notes in computer science","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/978-3-319-56154-7_48","article-title":"A clinical tool for automated flow cytometry based on machine learning methods","volume":"10209","author":"Takenga","year":"2017"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0160","doi-asserted-by":"crossref","first-page":"71915","DOI":"10.18632\/oncotarget.12430","article-title":"Automated analysis of acute myeloid leukemia minimal residual disease using a support vector machine","volume":"7","author":"Ni","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0165","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1109\/TBME.2016.2590950","article-title":"Automated assessment of disease progression in acute myeloid leukemia by probabilistic analysis of flow cytometry data","volume":"64","author":"Rajwa","year":"2017","journal-title":"IEEE Trans Biomed Eng"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/cyto.a.22810","article-title":"Automated analysis of flow cytometry data comes of age","volume":"89","author":"Brinkman","year":"2016","journal-title":"Cytometry A"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0175","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"Dohner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0180","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0165-4608(95)00084-4","article-title":"Correlation of cytogenetic results with immunophenotype, genotype, clinical features, and ras mutation in acute myeloid leukemia. A study of 235 Chinese patients in Taiwan","volume":"84","author":"Tien","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0185","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.leukres.2014.08.012","article-title":"Prognostic implication of gene mutations on overall survival in the adult acute myeloid leukemia patients receiving or not receiving allogeneic hematopoietic stem cell transplantations","volume":"38","author":"Chou","year":"2014","journal-title":"Leuk Res"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0190","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/leu.2013.236","article-title":"Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia","volume":"28","author":"Hou","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0195","series-title":"Support-vector networks. Machine learning","first-page":"273","volume":"20.3","author":"Corinna Cortes aVV","year":"1995"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0200","series-title":"Vlfeat: An open and portable library of computer vision algorithms. Proceedings of the 18th ACM international conference on Multimedia; Firenze, Italy. 1874249: ACM","first-page":"1469","author":"Vedaldi","year":"2010"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0205","series-title":"European conference on machine learning and principles and practices of knowledge discovery in databases","article-title":"API design for machine learning software: experiences from the scikit-learn project","author":"Buitinck","year":"2013"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0210","author":"R Core Team (2017)"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0215","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nri3158","article-title":"Standardizing immunophenotyping for the human immunology project","volume":"12","author":"Maecker","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0220","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.tibtech.2013.04.008","article-title":"Overview of clinical flow cytometry data analysis: Recent advances and future challenges","volume":"31","author":"Pedreira","year":"2013","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0225","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/1471-2105-15-314","article-title":"A non-parametric Bayesian model for joint cell clustering and cluster matching: identification of anomalous sample phenotypes with random effects","volume":"15","author":"Dundar","year":"2014","journal-title":"BMC Bioinform"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0230","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.patcog.2016.04.004","article-title":"Clustering of cell populations in flow cytometry data using a combination of Gaussian mixtures","volume":"60","author":"Reiter","year":"2016","journal-title":"Pattern Recog"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0235","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V126.23.2593.2593","article-title":"Improved detection of minimal residual disease by flow cytometry in AML by combining manual gating and visne clustering","volume":"126","author":"K\u00f6hnke","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0240","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.immuni.2015.04.006","article-title":"Thinking outside the gate: single-cell assessments in multiple dimensions","volume":"42","author":"Kvistborg","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0245","series-title":"Fisher kernels on visual vocabularies for image categorization. 2007 IEEE Conference on Computer Vision and Pattern Recognition; Minneapolis, MN","first-page":"1","author":"Perronnin","year":"2007"},{"key":"10.1016\/j.ebiom.2018.10.042_bb0250","first-page":"75","article-title":"Flow cytometry-based classification in cancer research: A view on feature selection","volume":"14","author":"Hassan","year":"2015","journal-title":"Cancer Inform"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418304602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418304602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:50:01Z","timestamp":1762455001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396418304602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":50,"alternative-id":["S2352396418304602"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.10.042","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.10.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}